Australia markets close in 4 hours 17 minutes

Entheon Biomedical Corp. (ENTBF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0644+0.0074 (+12.89%)
At close: 03:15PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.0570
Open0.0440
BidN/A x N/A
AskN/A x N/A
Day's range0.0440 - 0.0713
52-week range0.0280 - 0.5710
Volume4,980
Avg. volume18,558
Market cap4.176M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-0.1060
Earnings date28 Oct 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Ehave, Inc. Announces Psychedelics Precision Medicine Platform For Clinical Research

    AI-driven discovery platform enables new way to find novel pathways, as well as progress towards identifying patients who may better respond to drugs in the clinicGenetic test kit evaluates an individual's overall sensitivity and risk profile associated with psychedelic-assisted therapy MIAMI, June 01, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leading healthcare services and technology company, announced today its KetaDASH subsidiary will begin using precision med

  • GlobeNewswire

    Microdose Psychedelic Insights Presents the Upcoming DMT Conference, a Deep Dive Into the Dynamic Field of DMT Therapeutics

    NEW YORK, Aug. 30, 2021 (GLOBE NEWSWIRE) -- via NetworkNewsWire -- Microdose Psychedelic Insights, a cutting-edge media company focused on promoting content, financial analysis, and engaging events designed to drive the psychedelics industry into the forefront of modern medicine, will be hosting the upcoming DMT Conference in an entirely virtual format Sept. 9-10, 2021. The virtual event will explore the potential of DMT (“Dimethyltryptamine”) at the intersection of drug development and safety,